V. Wee Yong

Active 1984–2025

230
Papers
33,034
Citations
114
h-index
223
i10-index

Citations

Citations per year for V. Wee Yong1985: 6 citations1986: 8 citations1987: 5 citations1988: 10 citations1989: 14 citations1990: 10 citations1991: 23 citations1992: 29 citations1993: 27 citations1994: 46 citations1995: 49 citations1996: 49 citations1997: 79 citations1998: 95 citations1999: 150 citations2000: 143 citations2001: 191 citations2002: 195 citations2003: 245 citations2004: 294 citations2005: 312 citations2006: 320 citations2007: 320 citations2008: 264 citations2009: 259 citations2010: 265 citations2011: 255 citations2012: 282 citations2013: 262 citations2014: 267 citations2015: 287 citations2016: 261 citations2017: 302 citations2018: 312 citations2019: 877 citations2020: 1,073 citations2021: 1,184 citations2022: 1,246 citations2023: 980 citations2024: 1,395 citations2025: 794 citations2026: 16 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,873 citing papers, 26.4% of this breakdownChina: 1,842 citing papers, 12.6% of this breakdownCanada: 1,017 citing papers, 6.9% of this breakdownGermany: 929 citing papers, 6.3% of this breakdownUnited Kingdom: 864 citing papers, 5.9% of this breakdownItaly: 642 citing papers, 4.4% of this breakdownFrance: 401 citing papers, 2.7% of this breakdownSpain: 399 citing papers, 2.7% of this breakdownAustralia: 353 citing papers, 2.4% of this breakdownJapan: 343 citing papers, 2.4% of this breakdownNetherlands: 324 citing papers, 2.2% of this breakdownSwitzerland: 279 citing papers, 1.9% of this breakdown
0%26.4%Other 23.2%

Fields

  • Medicine40.4%
  • Neuroscience24%
  • Biochemistry, Genetics and Molecular Biology23.2%
  • Immunology and Microbiology7.4%
  • Agricultural and Biological Sciences1.1%
  • Engineering0.8%
  • Other3.1%

Topics

  • Neuroinflammation and Neurodegeneration Mechanisms9%
  • Multiple Sclerosis Research Studies3.8%
  • Neurogenesis and neuroplasticity mechanisms3.5%
  • Immune cells in cancer3.1%
  • Nerve injury and regeneration2.1%
  • Glioma Diagnosis and Treatment1.9%
  • Other76.6%

Coauthors

All papers

Open in search
  1. Multiple sclerosis progression: time for a new mechanism-driven framework

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , María Trojano, Anneke van der Walt, Sandra Vukusic, Emmaunelle Waubant - The Lancet Neurology 2022 cited by 615

  2. Single-cell RNA-seq reveals that glioblastoma recapitulates a normal neurodevelopmental hierarchy

    Authors: , , , , , , , , , , , , , , , , , , , - Nature Communications 2020 cited by 597

  3. Progressive multiple sclerosis: from pathophysiology to therapeutic strategies

    Authors: , , , - Nature Reviews Drug Discovery 2019 cited by 457

  4. Microglia in multiple sclerosis: Protectors turn destroyers

    Authors: - Neuron 2022 cited by 173

  5. Neuroinflammation in intracerebral haemorrhage: immunotherapies with potential for translation

    Authors: , - The Lancet Neurology 2020 cited by 316

  6. Inefficient clearance of myelin debris by microglia impairs remyelinating processes

    Authors: , , , , , , , , , - The Journal of Experimental Medicine 2015 cited by 604

  7. B cells in central nervous system disease: diversity, locations and pathophysiology

    Authors: , - Nature reviews. Immunology 2021 cited by 168

  8. Pathophysiology of the brain extracellular matrix: a new target for remyelination

    Authors: , , , , - Nature reviews. Neuroscience 2013 cited by 537

  9. Oxidized phosphatidylcholines found in multiple sclerosis lesions mediate neurodegeneration and are neutralized by microglia

    Authors: , , , , , , , , , , , , , - Nature Neuroscience 2021 cited by 178

  10. The extracellular matrix as modifier of neuroinflammation and remyelination in multiple sclerosis

    Authors: , - Brain 2021 cited by 182

  11. Expanding antigen-specific regulatory networks to treat autoimmunity

    Authors: , , , , , , , , , , , , , , , , , , - Nature 2016 cited by 504

  12. Mechanism-based criteria to improve therapeutic outcomes in progressive multiple sclerosis

    Authors: , - Nature Reviews Neurology 2021 cited by 161

  13. Glioma-derived IL-33 orchestrates an inflammatory brain tumor microenvironment that accelerates glioma progression

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2020 cited by 182

  14. Niacin-mediated rejuvenation of macrophage/microglia enhances remyelination of the aging central nervous system

    Authors: , , , , , , , , , , , , , , , , , , , , , - Acta Neuropathologica 2020 cited by 145

  15. Remyelination therapies: a new direction and challenge in multiple sclerosis

    Authors: , , - Nature Reviews Drug Discovery 2017 cited by 277

  16. Immunosenescence of microglia and macrophages: impact on the ageing central nervous system

    Authors: , , , , , - Brain 2016 cited by 255

  17. The intestinal barrier in multiple sclerosis: implications for pathophysiology and therapeutics

    Authors: , , , , - Brain 2018 cited by 184

  18. Oxidative Stress Following Intracerebral Hemorrhage: From Molecular Mechanisms to Therapeutic Targets

    Authors: , , , , , - Frontiers in Immunology 2022 cited by 120

  19. Microglia response following acute demyelination is heterogeneous and limits infiltrating macrophage dispersion

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Science Advances 2020 cited by 210

  20. Mechanisms of lysophosphatidylcholine‐induced demyelination: A primary lipid disrupting myelinopathy

    Authors: , , , , , , , , , , , , , , , - Glia 2017 cited by 208

  21. The Important Role of Zinc in Neurological Diseases

    Authors: , , , , - Biomolecules 2022 cited by 142

  22. The benefits of neuroinflammation for the repair of the injured central nervous system

    Authors: , , , , - Cellular and Molecular Immunology 2019 cited by 187

  23. When encephalitogenic T cells collaborate with microglia in multiple sclerosis

    Authors: , - Nature Reviews Neurology 2019 cited by 164

  24. Enhanced glycolytic metabolism supports transmigration of brain-infiltrating macrophages in multiple sclerosis

    Authors: , , , , , , - Journal of Clinical Investigation 2019 cited by 138